BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 6088805)

  • 1. Demonstration in vitro that eucaryotic initiation factor 3 is active but that a cap-binding protein complex is inactive in poliovirus-infected HeLa cells.
    Etchison D; Hansen J; Ehrenfeld E; Edery I; Sonenberg N; Milburn S; Hershey JW
    J Virol; 1984 Sep; 51(3):832-7. PubMed ID: 6088805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of HeLa cell protein synthesis following poliovirus infection correlates with the proteolysis of a 220,000-dalton polypeptide associated with eucaryotic initiation factor 3 and a cap binding protein complex.
    Etchison D; Milburn SC; Edery I; Sonenberg N; Hershey JW
    J Biol Chem; 1982 Dec; 257(24):14806-10. PubMed ID: 6294080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of cap-binding protein with eucaryotic initiation factor 3 in initiation factor preparations from uninfected and poliovirus-infected HeLa cells.
    Hansen J; Etchison D; Hershey JW; Ehrenfeld E
    J Virol; 1982 Apr; 42(1):200-7. PubMed ID: 6283140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variations in cap-binding complexes from uninfected and poliovirus-infected HeLa cells.
    Etchison D; Smith K
    J Biol Chem; 1990 May; 265(13):7492-500. PubMed ID: 2159001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isolation and structural characterization of cap-binding proteins from poliovirus-infected HeLa cells.
    Lee KA; Edery I; Sonenberg N
    J Virol; 1985 May; 54(2):515-24. PubMed ID: 2985814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The cap-binding protein complex in uninfected and poliovirus-infected HeLa cells.
    Buckley B; Ehrenfeld E
    J Biol Chem; 1987 Oct; 262(28):13599-606. PubMed ID: 2820976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two forms of purified m7G-cap binding protein with different effects on capped mRNA translation in extracts of uninfected and poliovirus-infected HeLa cells.
    Tahara SM; Morgan MA; Shatkin AJ
    J Biol Chem; 1981 Aug; 256(15):7691-4. PubMed ID: 6267020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Presence of the cap-binding protein in initiation factor preparations from poliovirus-infected HeLa cells.
    Hansen J; Ehrenfeld E
    J Virol; 1981 May; 38(2):438-45. PubMed ID: 6264121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adenovirus inhibition of cellular protein synthesis involves inactivation of cap-binding protein.
    Huang JT; Schneider RJ
    Cell; 1991 Apr; 65(2):271-80. PubMed ID: 1849798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Poliovirus protease does not mediate cleavage of the 220,000-Da component of the cap binding protein complex.
    Lloyd RE; Etchison D; Ehrenfeld E
    Proc Natl Acad Sci U S A; 1985 May; 82(9):2723-7. PubMed ID: 2986132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inactivation of cap-binding proteins accompanies the shut-off of host protein synthesis by poliovirus.
    Lee KA; Sonenberg N
    Proc Natl Acad Sci U S A; 1982 Jun; 79(11):3447-51. PubMed ID: 6954488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Purification of a factor that restores translation of vesicular stomatitis virus mRNA in extracts from poliovirus-infected HeLa cells.
    Trachsel H; Sonenberg N; Shatkin AJ; Rose JK; Leong K; Bergmann JE; Gordon J; Baltimore D
    Proc Natl Acad Sci U S A; 1980 Feb; 77(2):770-4. PubMed ID: 6244584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional characterization of eukaryotic mRNA cap binding protein complex: effects on translation of capped and naturally uncapped RNAs.
    Edery I; Lee KA; Sonenberg N
    Biochemistry; 1984 May; 23(11):2456-62. PubMed ID: 6089873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro translation in reovirus- and poliovirus-infected cell extracts. Effects of anti-cap binding protein monoclonal antibody.
    Sonenberg N; Skup D; Trachsel H; Millward S
    J Biol Chem; 1981 May; 256(9):4138-41. PubMed ID: 6260787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Separation of protein synthesis initiation factor eIF4A from a p220-associated cap binding complex activity.
    Etchison D; Milburn S
    Mol Cell Biochem; 1987 Jul; 76(1):15-25. PubMed ID: 3627111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of cell functions by RNA-virus infections.
    Kääriäinen L; Ranki M
    Annu Rev Microbiol; 1984; 38():91-109. PubMed ID: 6093688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Eukaryotic initiation factor 3 is required for poliovirus 2A protease-induced cleavage of the p220 component of eukaryotic initiation factor 4F.
    Wyckoff EE; Hershey JW; Ehrenfeld E
    Proc Natl Acad Sci U S A; 1990 Dec; 87(24):9529-33. PubMed ID: 2175904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Translation of glucose-regulated protein 78/immunoglobulin heavy-chain binding protein mRNA is increased in poliovirus-infected cells at a time when cap-dependent translation of cellular mRNAs is inhibited.
    Sarnow P
    Proc Natl Acad Sci U S A; 1989 Aug; 86(15):5795-9. PubMed ID: 2548189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of translation in cells infected with a poliovirus 2Apro mutant correlates with phosphorylation of the alpha subunit of eucaryotic initiation factor 2.
    O'Neill RE; Racaniello VR
    J Virol; 1989 Dec; 63(12):5069-75. PubMed ID: 2555543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction of translation initiation factor eIF4B with the poliovirus internal ribosome entry site.
    Ochs K; Saleh L; Bassili G; Sonntag VH; Zeller A; Niepmann M
    J Virol; 2002 Mar; 76(5):2113-22. PubMed ID: 11836388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.